Published in Biochemistry on February 29, 2000
Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure. Proc Natl Acad Sci U S A (2002) 1.65
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity. Blood (2012) 1.49
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proc Natl Acad Sci U S A (2004) 1.44
The role of hydrophobic interactions in positioning of peripheral proteins in membranes. BMC Struct Biol (2007) 1.20
Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V. Proc Natl Acad Sci U S A (2007) 0.96
Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII. J Mol Biol (2007) 0.96
A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex. Blood (2008) 0.95
Membrane-binding properties of the Factor VIII C2 domain. Biochem J (2011) 0.90
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine. Blood (2015) 0.89
Theoretical and experimental study of the D2194G mutation in the C2 domain of coagulation factor V. Biophys J (2004) 0.87
Location of the multimerin 1 binding site in coagulation factor V: an update. Thromb Res (2008) 0.75
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71
The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci (1995) 2.63
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J (1990) 2.44
X-ray crystallographic structure of the light-harvesting biliprotein C-phycocyanin from the thermophilic cyanobacterium Mastigocladus laminosus and its resemblance to globin structures. J Mol Biol (1985) 2.42
The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett (1991) 2.33
The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J Mol Biol (1975) 2.24
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J Mol Biol (1987) 2.06
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85
Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Nat Struct Biol (2001) 1.84
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol (1996) 1.82
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol (1977) 1.79
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Eur J Biochem (1987) 1.75
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
DDAVP in acquired hemophilia A: case report and review of the literature. Am J Hematol (1993) 1.69
Purification and characterization of human coagulation factor V. J Biol Chem (1981) 1.67
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci U S A (2000) 1.65
Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J (1990) 1.65
A player of many parts: the spotlight falls on thrombin's structure. Thromb Res (1993) 1.64
The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J (1988) 1.61
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol (1991) 1.60
Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature (1999) 1.58
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A (1995) 1.58
The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J (1996) 1.56
The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem (1992) 1.53
The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J (1996) 1.53
Crystal structure analysis and refinement at 2.5 A of hexameric C-phycocyanin from the cyanobacterium Agmenellum quadruplicatum. The molecular model and its implications for light-harvesting. J Mol Biol (1986) 1.50
Inflammation, sepsis, and coagulation. Haematologica (1999) 1.49
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry (1995) 1.48
Functional analysis of Cdc42 in actin filament assembly, epithelial morphogenesis, and cell signaling during Drosophila development. Dev Biol (2000) 1.45
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J (1995) 1.45
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature (1998) 1.43
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor. FEBS Lett (1989) 1.38
First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J (1993) 1.36
Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin. J Mol Biol (1993) 1.34
Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin. FEBS Lett (1976) 1.34
Refined three-dimensional structure of phycoerythrocyanin from the cyanobacterium Mastigocladus laminosus at 2.7 A. J Mol Biol (1990) 1.33
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition. J Biol Chem (1996) 1.33
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett (1994) 1.32
The clot thickens: clues provided by thrombin structure. Trends Biochem Sci (1995) 1.30
Lysis inhibition in Escherichia coli infected with bacteriophage T4. J Virol (1967) 1.30
Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem (1980) 1.28
Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J Biol Chem (1998) 1.24
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest (1986) 1.22
Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci U S A (1986) 1.22
Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struct Biol (1995) 1.22
The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc Natl Acad Sci U S A (2001) 1.21
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood (1979) 1.20
Implications of the three-dimensional structure of astacin for the structure and function of the astacin family of zinc-endopeptidases. Eur J Biochem (1993) 1.20
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. J Mol Biol (1992) 1.18
The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition. J Biol Chem (2001) 1.17
Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J Mol Biol (1991) 1.17
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J (1996) 1.17
Structure of astacin with a transition-state analogue inhibitor. Nat Struct Biol (1996) 1.17
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem (1995) 1.15
Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc Natl Acad Sci U S A (1994) 1.14
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood (1993) 1.13
The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. J Biol Chem (1992) 1.13
The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3). Eur J Biochem (1985) 1.10
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. Structure (1999) 1.09
Crystal structure of a coagulogen, the clotting protein from horseshoe crab: a structural homologue of nerve growth factor. EMBO J (1996) 1.09
Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem (1992) 1.09
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol (2001) 1.08
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood (1998) 1.08
Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J (1997) 1.08
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J (2000) 1.08
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2. J Mol Biol (2006) 1.07
Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J Mol Biol (1981) 1.06
The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C. EMBO J (1995) 1.06
Structure of proline iminopeptidase from Xanthomonas campestris pv. citri: a prototype for the prolyl oligopeptidase family. EMBO J (1998) 1.05
Structure and function of lysosomal cysteine proteinases and their protein inhibitors. Prog Clin Biol Res (1985) 1.05
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases. FEBS Lett (1996) 1.04